Literature DB >> 17223379

Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugs.

Hanaa M Saleh1, Magda M El-Henawee, Gamal H Ragab, Soad S Abd El-Hay.   

Abstract

A simple, accurate, precise and sensitive colorimetric method for the determination of some skeletal muscle relaxant drugs, namely orphenadrine citrate (I), baclofen (II), antihistaminic drugs as acrivastine (III) and fexofenadine hydrochloride (IV) is described. This method is based on the formation of charge transfer complex with 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) in non-aqueous medium. The orange color products were measured at 472, 465, 475 and 469 nm for drugs I, II, III and IV, respectively. The optimization of various experimental conditions was described. Beer's Law was obeyed in the range (2.5-17.5), (5-70), (2.5-25) and (10-50)microg/ml for drugs I, II, III and IV, respectively. The molar absorptivity (epsilon), sandell sensitivity, detection((LOD)) and quantitation limits((LOQ)) are calculated. The procedure was favorably applied for determination of certain pharmaceutical dosage forms containing the studied drugs. The obtained results were compared with the official and reported methods. There were no significant differences between proposed, reported and the official methods.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17223379     DOI: 10.1016/j.saa.2006.09.039

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  9 in total

1.  Validated spectroflurimetric determination of some H1 receptor antagonist drugs in pharmaceutical preparations through charge transfer complexation.

Authors:  Mohie K Sharaf el-Din; Fawzia Ibrahim; Manal I Eid; Mary E K Wahba
Journal:  J Fluoresc       Date:  2011-08-10       Impact factor: 2.217

2.  Development of a capillary electrophoresis method for the determination of orphenadrine citrate in tablets in the presence of paracetamol.

Authors:  Dana N Haj-Ali; Imad I Hamdan
Journal:  Saudi Pharm J       Date:  2010-08-02       Impact factor: 4.330

3.  Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations.

Authors:  Soad S Abd el-Hay; Christa L Colyer; Wafaa S Hassan; Abdalla Shalaby
Journal:  J Fluoresc       Date:  2011-08-19       Impact factor: 2.217

4.  Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).

Authors:  M Walsh; F Belal; Nahed El-Enany; H Elmansi
Journal:  J Fluoresc       Date:  2010-07-01       Impact factor: 2.217

5.  Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  J Fluoresc       Date:  2008-10-23       Impact factor: 2.217

6.  Spectrophotometric determination of tizanidine and orphenadrine via ion pair complex formation using eosin Y.

Authors:  Mohamed I Walash; Fathalla F Belal; Manal I Eid; Samah Abo El Abass Mohamed
Journal:  Chem Cent J       Date:  2011-10-08       Impact factor: 4.215

7.  Simple mix-and-read assays for the determination of baclofen in pharmaceutical formulation.

Authors:  Amira F El-Yazbi; Karin M Guirguis; Mona M Bedair; Tarek S Belal
Journal:  Heliyon       Date:  2019-06-07

8.  New spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasma.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  Anal Chem Insights       Date:  2008-11-18

9.  New spectrophotometric and fluorimetric methods for determination of fluoxetine in pharmaceutical formulations.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  Int J Anal Chem       Date:  2009-08-16       Impact factor: 1.885

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.